Results 11 to 20 of about 125,156 (180)
Innovations in the systemic treatment of medullary thyroid cancer with kinase inhibitors
Journal of Education, Health and Sport, 2023 Introduction: Medullary thyroid carcinoma is a primary thyroid neoplasm originating from thyroid C cells. It can be familial or sporadic. The familial form is associated with multiple endocrine neoplasia (MEN) syndrome types 2A and 2B and is caused by a
Wiktoria Lipczyńska +7 more
doaj +1 more source
Principles of medullary thyroid cancer staging according to AJCC TNM 8th edition
Acta Medica Leopoliensia, 2021 Aim. The research aims at analyzing the main changes in classification of medullary thyroid cancer and outlining the principles of staging according to modern studies. Material and Methods.
O.R Duda, R.R. Slipetsky, N.I. Bojko
doaj +1 more source
Current Oncology, 2022 Selpercatinib, a RET kinase inhibitor, is an effective treatment for patients with medullary thyroid cancer with RET mutations. In this paper, we present the case of a 62-year-old man with ectopic Cushing’s syndrome due to medullary thyroid cancer who ...
Oskar Ragnarsson +2 more
doaj +1 more source
Frontiers in Endocrinology, 2021 BackgroundSevere acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel coronavirus that has caused a worldwide pandemic. The majority of medullary thyroid cancers present as a thyroid nodule.
Livia Sira +7 more
doaj +1 more source
Ukrainian Scientific Medical Youth Journal, 2021 the aim of the stydy was to analyze the detectability of medullary thyroid metastases in patients at treatment and diagnostic stages, to investigate the applicability of serum calcitonin level as predictor of possible presence of medullary thyroid ...
Volodymyr Palamarchuk +6 more
doaj +1 more source
Combination of medullary thyroid cancer and renal cell carcinoma in one patient
Клиническая и экспериментальная тиреоидология, 2018 Patients who received treatment for the first malignant neoplasm remain in the group at increased risk of developing a second primary tumor throughout their later life.
Yuliya A. Dolinskaya +4 more
doaj +1 more source
Surgical Oncology Clinics of North America, 2006 The goal in managing patients who have MTC is to detect and surgically remove disease at an early stage. Tumor marker-based biochemical screening and DNA-based genetic screening have created the opportunity for effective prophylactic surgery in patients at risk for hereditary MTC.
Y Nancy, You +3 more
openaire +4 more sources
Educational Case: Endocrine Neoplasm
Academic Pathology, 2018 Medullary thyroid cancer is a rare neuroendocrine tumor that arises the neural crest-derived parafollicular C cells and accounts for approximately 5% to 10% of thyroid cancers worldwide.
Sheila Segura MD +2 more
doaj +1 more source
Breast metastasis from medullary thyroid carcinoma: a report of a case
Surgical Case Reports, 2021 Background Metastasis to the breast is rare. We herein report a patient with metastatic medullary thyroid carcinoma to the breast for whom measuring the calcitonin level was an important clue to the correct diagnosis.
Yoko Omi +6 more
doaj +1 more source
Human Pathology Reports, 2022 Tumour-to-tumour metastasis is a rare incidence. Metastasis from colorectal cancer to primary thyroid neoplasm is extremely rare. We report a case of metastatic rectal adenocarcinoma to a medullary thyroid carcinoma.
Mahmoud Elsayed +2 more
doaj +1 more source